Rational design of tetrahydrotetrazinones as potent nonclassical radical-trapping antioxidants for inhibition of ferroptosis
Science Advances · 2026-02-27 · 12 (9)
DOI: 10.1126/sciadv.aec2190 ↗At a glance
Journal article in Science Advances, published on 2026-02-27. Written by Cuiling Ouyang and 2 co-authors. Institution: State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, Sch…. Major MEDLINE topics: Ferroptosis, Antioxidants, Drug Design. Cited 5 times so far (Crossref); 71 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, The Fundamental Research Funds for the Central Universities, Sun Yat-sen University.
Abstract (original language)
Radical-trapping antioxidant (RTA) protection plays a critical role in industrial, biological, and pharmaceutical contexts. The cytoprotective role of RTAs has been increasingly recognized as essential in regulating ferroptosis, a form of regulated cell death driven by lipid peroxidation. However, current ferroptosis inhibitors primarily rely on phenolic or aromatic amine scaffolds, which were found through high-throughput screening or derived from historically known RTAs. We introduce hydrazine-derived tetrahydro-1,2,4,5-tetrazin-3-ones (THTZOs) as a class of nonclassical RTAs. THTZOs operate via a unique mechanism involving hydrazyl and verdazyl radical intermediates that is independent of aromatic stabilization. These compounds demonstrate broad reactivity against autoxidation in both simple hydrocarbons and membrane phospholipids, effectively suppressing ferroptosis induced by RAS-selective lethal 3 (RSL3) or erastin in multiple cell lines. Our findings revitalize the application of hydrazine derivatives in RTA chemistry and establish a foundation for the rational design of RTAs as potent ferroptosis inhibitors, offering previously unidentified antioxidant therapeutic candidates.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 5100…
ORCID profiles: Jiaying Huang, Zijun Wu
Funding
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- The Fundamental Research Funds for the Central Universities, Sun Yat-sen University
Cite
APA
Ouyang, C., Huang, J., & Wu, Z. (2026). Rational design of tetrahydrotetrazinones as potent nonclassical radical-trapping antioxidants for inhibition of ferroptosis. Science Advances, 12(9). https://doi.org/10.1126/sciadv.aec2190
Vancouver
Ouyang C, Huang J, Wu Z. Rational design of tetrahydrotetrazinones as potent nonclassical radical-trapping antioxidants for inhibition of ferroptosis. Science Advances. 2026;12(9). doi:10.1126/sciadv.aec2190
BibTeX
@article{Ouyang2026,
author = {Ouyang, Cuiling and Huang, Jiaying and Wu, Zijun},
title = {Rational design of tetrahydrotetrazinones as potent nonclassical radical-trapping antioxidants for inhibition of ferroptosis},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {9},
doi = {10.1126/sciadv.aec2190}
}
EUVIMED